Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication

Abstract EN

We determined cancer comorbidity in patients with diabetes followed up at a single Greek academic clinic and investigated the potential related factors.

Cancer comorbidity was prospectively recorded for all patients with type 2 (T2DM, n = 759 ) or type 1 (T1DM, n = 134 ) diabetes of at least 10-year duration examined during one year.

Patient characteristics, diabetes age of onset, duration, treatment, control, and complication rates were compared between subjects with and without cancer.

Moreover, a retrospective collection of data from similar patients examined for the first time during the last 25 years, but lost to follow-up, after at least one-year’s regular visits, was performed.

In regularly followed-up T2DM patients cancer comorbidity was 12.6%.

Patients with cancer were older and more frequently smokers.

Prostate cancer was the most frequent (24.0%) type.

In T1DM cancer comorbidity was 3.0%.

Similar rates of comorbidity and types of cancer were observed in lost to follow-up patients.

In conclusion, our patients with T2DM of at least 10-year’ duration show high cancer comorbidity.

No specific characteristics discriminate patients with cancer.

Therefore presymptomatic cancer detection and prevention strategies may have to be incorporated into the annual systematic evaluation of our patients.